Mix-and-Match Vaccine Platform May Boost Immune Response & Duration

The Infectious Disease Research Institute (IDRI), a non-profit biotech organization, is working with a newly-formed consortium to develop a next-gen COVID-19 vaccine that will be stable at routine temperatures and that may be able to confer immunity for a longer duration.